Improving vascular access
Ebnet Medical aims to advance the continuum of vascular access care through multiple needs-driven product developments.
The founder, a specialist in anaesthesiology, intensive care medicine and emergency medicine, is still an active emergency doctor.
Access to the vascular system is a critical step in life-saving infusion therapy and one of the most common invasive procedures in medicine, with billions of vascular catheters sold worldwide each year.
Despite the highest standards in modern medicine, traditional vascular catheters often cause pain and anxiety, with high failure and complication rates.
Children and vulnerable patients are particularly affected.
Jens Ebnet is a member of the IVAM
Ebnet Medical designed for more precise access to smaller blood vessels with one hand without a guide wire.
Ultrasound can be applied continuously by other hand.
Innovative click mechanism to confirm the defined advancement of the catheter over the stable needle.
Improved catheter and needle control, even for beginners.
Protective box for sterile integrity of infusion set connector..
Slotted hub design for catheter patency.
Innovative attachment wings..
Patent application has been filed.
Designed for easy and safe access to larger blood vessels without a guide wire.
All components integrated..
Sterile and robust design..
Patents granted and pending.
skin fixation components.
Developed for the reliable fixation of vascular catheters to the skin.
No need for strong band-aids. Patent application has been filed.
Ebnet Medical Peripheral Intravenous Catheter (PIVC)
Paves Peripheral Intravenous Catheter (PIVC)
The innovative Ebnet PIVC was developed to reduce future common, serious and costly complications.
Its design enables easy and safe integration into existing workflows.
The aim is to keep costs low, supply chains short and to reduce waste and carbon footprint.
For a better world and patient care!
Up to 90% of hospital patients receive an indwelling venous catheter. The failure rate is up to 50%, even with the best care. Complications are common and can be life-threatening. 1
The first attempt at insertion fails
absent in up to 26% of adults and up to 54% of children. 2
Reach up to 50% of indwelling venous catheters
not their intended duration of use. 3
The duration of use of indwelling venous catheters is often shortened due to complications and leads to frequent new installations. 4
This puts a significant strain on healthcare systems.
Huge savings potential in a growing market worth billions. Avoiding IV catheter restarts can save a 200-bed hospital over $980,000 annually. 5
(1) Accepted but not acceptable: Peripheral IV catheter failure – PubMed (nih.gov)
(2) Failed Attempts and Strategies for Improvement in Peripheral Intravenous Catheterization – PubMed (nih.gov)
(3) Peripheral Intravenous Catheters Market Size and Forecast | FMI (futuremarketinsights.com)
(4) Doomed Peripheral Intravenous Catheters: Poor Outcomes Are Similar for ER and Inpatient Catheters: A Retrospective Review of Medical Records – PubMed (nih.gov)
(5) Vascular Access Management (bd.com)
dr medical Jens Ebnet, M.Sc., D.E.S.A.
“Improving vascular access and patient care 24/7 with my amazing team and network is my passion!”
Ebnet Medical – Innovation from practice for practice
Demand-driven innovations from active specialists
Simplicity, security and efficiency to maximize value
Ebnet Medical – Securing Intellectual Property
Extensive IP portfolio with a focus on vascular access
11 German patent applications + corresponding international applications filed (coverage of up to 9 regions/countries worldwide per application)
Strong US IP strategy including divisional application
Patents granted in USA, Australia and Brazil, applications accepted in EU and China (under revision)
> 10 brands and > 190 domains registered